Funder: The Mark Foundation for Cancer Research

Due Dates (Anticipated): January 21, 2026 (LOI portal opens) | February 28, 2026 (LOI deadline) | April 2026 (Full application invitation) | August 2026 (Award start)

Funding Amounts: Up to $250,000 for a 12-month project period; indirect costs capped at 10% of direct costs.

Summary: Supports innovative, high-risk projects addressing feasibility and proof-of-concept questions in cancer research, with a focus on intrinsically disordered proteins and cancer.

Key Information: Open to independent researchers at non-profit institutions worldwide; only one application per PI per cycle.